These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2968287)

  • 1. The correlation between sensory nerve conduction velocities and three metabolic indices in rats treated with streptozotocin.
    Julu PO
    Diabetologia; 1988 Apr; 31(4):247-53. PubMed ID: 2968287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of short-term effects of insulin and essential fatty acids on the slowed nerve conduction of streptozotocin diabetes in rats.
    Julu PO; Mutamba A
    J Neurol Sci; 1991 Nov; 106(1):56-9. PubMed ID: 1663993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of chronic alpha-adrenergic receptor blockade on peripheral nerve conduction, hypoxic resistance, polyols, Na(+)-K(+)-ATPase activity, and vascular supply in STZ-D rats.
    Cameron NE; Cotter MA; Ferguson K; Robertson S; Radcliffe MA
    Diabetes; 1991 Dec; 40(12):1652-8. PubMed ID: 1661693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention and reversal of motor and sensory peripheral nerve conduction abnormalities in streptozotocin-diabetic rats by the prostacyclin analogue iloprost.
    Cotter MA; Dines KC; Cameron NE
    Naunyn Schmiedebergs Arch Pharmacol; 1993 May; 347(5):534-40. PubMed ID: 7686634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effect of Org 2766 in treatment of peripheral neuropathy in streptozocin-induced diabetic rats.
    Van der Zee CE; Van der Hoop RG; Gispen WH
    Diabetes; 1989 Feb; 38(2):225-30. PubMed ID: 2536628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of evening primrose oil on nerve function and capillarization in streptozotocin-diabetic rats: modulation by the cyclo-oxygenase inhibitor flurbiprofen.
    Cameron NE; Cotter MA; Dines KC; Robertson S; Cox D
    Br J Pharmacol; 1993 Aug; 109(4):972-9. PubMed ID: 8401950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced urinary bladder afferent conduction velocities in streptozocin diabetic rats.
    Nadelhaft I; Vera PL
    Neurosci Lett; 1992 Feb; 135(2):276-8. PubMed ID: 1625809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of deficits in axonal transport and nerve conduction velocity by treatment of streptozotocin-diabetic rats with myo-inositol.
    Tomlinson DR; Mayer JH
    Exp Neurol; 1985 Aug; 89(2):420-7. PubMed ID: 2410289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a new aldose reductase inhibitor, (2S, 4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-ca rboxamid e (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute streptozotocin-induced diabetic rats.
    Mizuno K; Kato N; Matsubara A; Nakano K; Kurono M
    Metabolism; 1992 Oct; 41(10):1081-6. PubMed ID: 1328819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldose reductase inhibition with imirestat-effects on impulse conduction and insulin-stimulation of Na+/K(+)-adenosine triphosphatase activity in sciatic nerves of streptozotocin-diabetic rats.
    Carrington AL; Ettlinger CB; Calcutt NA; Tomlinson DR
    Diabetologia; 1991 Jun; 34(6):397-401. PubMed ID: 1653157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amelioration by the Ca2+ antagonist, nimodipine of an existing neuropathy in the streptozotocin-induced, diabetic rat.
    Kappelle AC; Bravenboer B; van Buren T; Traber J; Erkelens DW; Gispen WH
    Br J Pharmacol; 1993 Mar; 108(3):780-5. PubMed ID: 8467365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Latency of neuroactivity and optimum period of treatment with evening primrose oil in diabetic rats.
    Julu PO
    J Lipid Mediat Cell Signal; 1996 Mar; 13(2):99-113. PubMed ID: 8925199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of orally active poly(ADP-ribose) polymerase inhibitor in streptozotocin-diabetic rat model of early peripheral neuropathy.
    Li F; Szabó C; Pacher P; Southan GJ; Abatan OI; Charniauskaya T; Stevens MJ; Obrosova IG
    Diabetologia; 2004 Apr; 47(4):710-7. PubMed ID: 15298348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of capsaicin application to a peripheral nerve on impulse conduction in functionally identified afferent nerve fibres.
    Petsche U; Fleischer E; Lembeck F; Handwerker HO
    Brain Res; 1983 Apr; 265(2):233-40. PubMed ID: 6850326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrasting effects of treatment with omega-3 and omega-6 essential fatty acids on peripheral nerve function and capillarization in streptozotocin-diabetic rats.
    Dines KC; Cotter MA; Cameron NE
    Diabetologia; 1993 Nov; 36(11):1132-8. PubMed ID: 8270127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conduction velocity changes along the processes of rat primary sensory neurons.
    Waddell PJ; Lawson SN; McCarthy PW
    Neuroscience; 1989; 30(3):577-84. PubMed ID: 2771039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piroxicam may reduce the rate of progression of experimental diabetic neuropathy.
    Parry GJ; Kozu H
    Neurology; 1990 Sep; 40(9):1446-9. PubMed ID: 2392233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of mixed bovine brain gangliosides on hypoxic conduction block in control and streptozotocin-diabetic rats.
    Calcutt NA; Carrington AL; Ettlinger CB; Tomlinson DR
    J Neurol Sci; 1992 May; 109(1):96-101. PubMed ID: 1387680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TX14(A), a prosaposin-derived peptide, reverses established nerve disorders in streptozotocin-diabetic rats and prevents them in galactose-fed rats.
    Mizisin AP; Steinhardt RC; O'Brien JS; Calcutt NA
    J Neuropathol Exp Neurol; 2001 Oct; 60(10):953-60. PubMed ID: 11589426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats.
    Mayer JH; Tomlinson DR
    Diabetologia; 1983 Nov; 25(5):433-8. PubMed ID: 6197336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.